PancreaKare Powder: unauthorized product with undeclared ingredient pancreatin
Brand(s)
Last updated
Summary
Product
PancreaKare Powder
Issue
Health products - Unauthorized product
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
PancreaKare Powder |
PancreaKare Powder |
No Market Authorization |
Powder |
N/A |
23PKP05111, 23PKP05161, 23PKP05191, 23PKP05231 |
Issue
Product sold without market authorization (DIN) Canada. Product contains undeclared pancreatin that is listed on the Prescription Drug List (provides more than 20 000 USP units of lipase activity/dose).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Distributors
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
Alberta Veterinary Laboratories Ltd.
7226 107 Ave. SE, Calgary
Alberta, T2C 5N6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74666
History
Change log
2023-11-29: Updated title
Get notified
Receive notifications for new and updated recalls and alerts by category.